866-997-4948(US-Canada Toll Free)

Bladder Cancer Global Clinical Trials Review, Q4, 2010

Published By :

GlobalData

Published Date : Oct 2010

Category :

Bladder Cancer

No. of Pages : 65 Pages

 

 

GlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, Q4, 2010"" provides data on the Bladder Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Bladder Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Bladder Cancer). 

 

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. 

 

Scope

 

  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others

Reasons to buy

 

  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

1 Table of Contents

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6

2 Introduction 7
2.1 Bladder Cancer 7
2.2 Report Guidance 7

3 Clinical Trials by Region 8
3.1 Clinical Trials by Country 9
3.1.1 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
3.1.2 Top Five Countries Contributing to Clinical Trials in Europe 12
3.1.3 Top Countries Contributing to Clinical Trials in North America 13
3.1.4 Top Countries Contributing to Clinical Trials in Middle East and Africa 14
3.1.5 Top Five Countries Contributing to Clinical Trials in Central and South America 15
3.2 Clinical Trials by BRIC Countries 16

4 Clinical Trials by Phase 17
4.1 In Progress Trials by Phase 19

5 Clinical Trials by Trial Status 20
5.1 Unaccomplished Trials of Bladder Cancer 22

6 Subjects Recruited Over a Period of Time 24
6.1 Prominent Sponsors 25
6.2 Top 10 Companies Participating in Bladder Cancer Clinical Trials 27

7 Prominant Drug Comparison 29

8 Clinical Trial Profiles 30

8.1 Clinical Trial Overview of Top 20 Companies 30
8.1.1 Eli Lilly and Company 30
8.1.2 Bristol-Myers Squibb Company 31
8.1.3 Hoosier Oncology Group, Inc. 32
8.1.4 Oncogenex Pharmaceuticals, Inc. 33
8.1.5 Medwerex, Inc. (Inactive) 34
8.1.6 Merck & Co., Inc. 34
8.1.7 Halozyme Therapeutics, Inc. 35
8.1.8 Spectrum Pharmaceuticals, Inc. 36
8.1.9 Endo Pharmaceuticals Holdings Inc. 36
8.1.10 Anthera Pharmaceuticals Inc. 37
8.1.11 Pfizer Inc. 37
8.1.12 Eisai Co., Ltd. 38
8.1.13 AstraZeneca PLC 38
8.1.14 Photocure ASA 39
8.1.15 Predictive Biosciences, Inc. 39
8.1.16 Tengion, Inc. 40
8.1.17 MacroGenics, Inc. 40
8.1.18 Theradex Systems, Inc. 41
8.1.19 Genzyme Oncology 41
8.1.20 Fujirebio Inc.ogy 42
8.2 Clinical Trial Overview by Top 20 Universities / Institutes / Hospitals 42
8.2.1 National Cancer Institute (NCI) 42
8.2.2 European Organization for Research and Treatment of Cancer 47
8.2.3 Memorial Sloan Kettering Cancer Center 49
8.2.4 The University of Texas M. D. Anderson Cancer Center 51
8.2.5 The University of Chicago 53
8.2.6 Cancer Research UK 54
8.2.7 Cancer Prevention Institute of California 54
8.2.8 Mary Babb Randolph Cancer Center 55
8.2.9 University of Michigan Comprehensive Cancer Center 56
8.2.10 Dana-Farber Cancer Institute 57
8.2.11 Roswell Park Cancer Institute 57
8.2.12 Stanford University 58
8.2.13 Hokkaido University School of Medicine 58
8.2.14 The National Institute for Cancer Research 59
8.2.15 All India Institute of Medical Sciences 59
8.2.16 Wake Forest University 59
8.2.17 Indiana University School of Medicine 60
8.2.18 Association of Urogenital Oncology (AUO) 60
8.2.19 Hospital del Mar 60
8.2.20 Hebrew University of Jerusalem 61

9 Appendix 62
9.1 Abbreviations 62
9.2 Definitions 62
9.3 Research Methodology 63
9.4 Secondary Research 64
9.5 About GlobalData 64
9.6 Contact Us 64
9.7 Disclaimer 65
9.8 Source 65
 

List of Table


Table 1: Bladder Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2010* 8
Table 2: Bladder Cancer Therapeutics Clinical Trials and in Progress Trials Market, Global, by Top Countries, 2010* 10
Table 3: Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2010* 11
Table 4: Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2010* 12
Table 5: Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries, 2010* 13
Table 6: Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2010* 14
Table 7: Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2010* 15
Table 8: Bladder Cancer Clinical Trials by BRIC Countries, 1982-2010* 16
Table 9: Bladder Cancer Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010* 18
Table 10: Bladder Cancer Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010* 19
Table 11: Bladder Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 21
Table 12: Bladder Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2010* 22
Table 13: Bladder Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2010* 22
Table 14: Bladder Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2010* 22
Table 15: Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 26
Table 16: Bladder Cancer Clinical Trials, Top Ten Companies by Phase, 2010* 28
Table 17: Bladder Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010* 29
Table 18: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2010* 30
Table 19: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2010* 31
Table 20: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoosier Oncology Group, Inc., 2010* 32
Table 21: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncogenex Pharmaceuticals, Inc., 2010* 33
Table 22: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medwerex, Inc. (Inactive), 2010* 34
Table 23: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2010* 34
Table 24: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Halozyme Therapeutics, Inc., 2010* 35
Table 25: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo Pharmaceuticals Holdings Inc., 2010* 36
Table 26: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo Pharmaceuticals Holding Inc., 2010* 36
Table 27: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals Inc., 2010* 37
Table 28: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2010* 37
Table 29: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2010* 38
Table 30: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2010* 38
Table 31: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Photocure ASA, 2010* 39
Table 32: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Predictive Biosciences, Inc, 2010* 39
Table 33: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Tengion, Inc, 2010* 40
Table 34: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MacroGenics, Inc, 2010* 40
Table 35: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Theradex Systems, Inc, 2010* 41
Table 36: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Oncology, 2010* 41
Table 37: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fujirebio Inc.ongy, 2010* 42
Table 38: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2010* 43
Table 39: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2010* 47
Table 40: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2010* 49
Table 41: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2010* 51
Table 42: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2010* 53
Table 43: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Research UK, 2010* 54
Table 44: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Prevention Institute of California, 2010* 54
Table 45: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mary Babb Randolph Cancer Center, 2010* 55
Table 46: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2010* 56
Table 47: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2010* 57
Table 48: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2010* 57
Table 49: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2010* 58
Table 50: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University School of Medicine, 2010* 58
Table 51: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute for Cancer Research, 2010* 59
Table 52: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2010* 59
Table 53: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2010* 59
Table 54: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2010* 60
Table 55: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Association of Urogenital Oncology (AUO), 2010* 60
Table 56: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital del Mar, 2010* 60
Table 57: Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hebrew University of Jerusalem, 2010* 61

List of Chart


Figure 1: Bladder Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2010* 8
Figure 2: Bladder Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 9
Figure 3: Bladder Cancer Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2010* 10
Figure 4: Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2010* 11
Figure 5: Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010* 12
Figure 6: Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2010* 13
Figure 7: Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2010* 14
Figure 8: Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2010* 15
Figure 9: Bladder Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2010* 16
Figure 10: Bladder Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2010* 17
Figure 11: Bladder Cancer Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010* 19
Figure 12: Bladder Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 20
Figure 13: Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 25
Figure 14: Bladder Cancer Clinical Trials, Top Ten Companies by Phase, 2010* 27
Figure 15: Bladder Cancer Therapeutics Clinical Trials, Global, Clinical Trials in Progress by Prominent Drugs, 2010* 29
Figure 16: GlobalData Methodology 63

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *